Author:
Shi Danrong,Chen Keda,Lu Xiangyun,Cheng Linfang,Weng Tianhao,Liu Fumin,Wu Nanping,Li Lanjuan,Yao Hangping
Subject
Virology,Molecular Medicine,Immunology
Reference34 articles.
1. An open-label randomized, controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19;Ader;Clin. Microbiol. Infect.,2021
2. Ganciclovir;Al-Badr;Profiles Drug Subst. Excip. Relat. Methodol.,2018
3. Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: an evaluation of the evidence;Cao;Trav. Med. Infect. Dis.,2020
4. COVID-19: SARS-CoV-2 Variant Classifications and Definitions;Centers for Disease Control and Prevention (CDC),2021
5. A multi-center randomized prospective study on the treatment of infant bronchiolitis with interferon alpha1b nebulization;Chen;PLoS One,2020
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献